All StatesIowaAudubon CountyRandy Feenstra › Evidence
Neutral Bill Mar 16, 2026

To amend the National Quantum Initiative Act to make certain additions relating to quantum modeling and simulation, and for other purposes.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7749 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7749 To amend the National Quantum Initiative Act to make certain additions relating to quantum modeling and simulation, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 2, 2026 Mr. Feenstra (for himself, Ms. Stevens, Mr. Valadao, Mrs. Miller-Meeks, Mr. Kean, Mr. Wittman, Mr. Yakym, Mr. Lawler, Ms. McBride, and Ms. Lofgren) introduced the following bill; which was referred to the Committee on Science, Space, and Technology _______________________________________________________________________ A BILL To amend the National Quantum Initiative Act to make certain additions relating to quantum modeling and simulation, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Quantum in Practice Act''. SEC. 2. FINDINGS. Congress finds the following: (1) Quantum computing has the potential to spur advancements in molecular modeling and simulation that will benefit Americans. (2) Quantum molecular simulations and modeling will enable scientists to study chemical elements and reactions with accuracy and speed that is far beyond the abilities of existing supercomputers. (3) Advances in molecular simulations and modeling would give researchers tools that could lead to breakthroughs across industries and sectors, including-- (A) modeling the nitrogen fixation process utilized by bacteria, which could be used to develop synthetic fertilizers without the high energy and material costs of current methods, creating the next generation of fertilizers; (B) creating more effective medications and reducing harmful interactions or side effects; (C) developing new materials to increase energy storage capacity and creat

https://www.congress.gov/bill/119th-congress/house-bill/7749
Randy Feenstra U.S. Representative Thomas Kean U.S. Representative Cosponsor Zoe Lofgren U.S. Representative Cosponsor Sarah McBride U.S. Representative Cosponsor John McGuire U.S. Representative Cosponsor Mariannette Miller-Meeks U.S. Representative Cosponsor Joe Neguse U.S. Representative Cosponsor John Rose U.S. Representative Cosponsor Haley Stevens U.S. Representative Cosponsor David Valadao U.S. Representative Cosponsor Robert Wittman U.S. Representative Cosponsor Rudy Yakym U.S. Representative Cosponsor
Share on X Share on Facebook
← Back to Randy Feenstra's profile